Issues
-
Cover Image
Cover Image
A long-standing question in cancer biology is why women who have their first child early in life have a lower lifetime risk of developing breast cancer. To investigate the basis for this phenomenon, Blakely et al. used microarray expression profiling to identify persistent pregnancy-induced changes in mammary gene expression that are tightly associated with protection against tumorigenesis in four different rat models.Expression profiling of parous and nulliparous mammary tissue yielded a common 70-gene signature that implicates alterations in TGF- signaling, extracellular matrix(ECM) proteins, amphiregulin expression, and the growth hormone-Igf1 axis in the pregnancy-induced reduction in breast cancer risk (right panel). The down-regulation of ECM protein expression by pregnancy is illustrated by Mason.s Trichrome-stained nulliparous (top left) and parous (bottom left) mammary glands. The conservation of this gene expression signature suggests that persistent alterations in these pathways may contribute to pregnancy-induced protection against breast cancer. For details,see the article by Blakely et al. on page 6421 of this issue.
- PDF Icon PDF LinkTable of Contents
Cancer Research
Table of Contents
Reviews
Priority Reports
Molecular Biology, Pathobiology, and Genetics
Multiple Imprinted and Stemness Genes Provide a Link between Normal and Tumor Progenitor Cells of the Developing Human Kidney
Integrative Genomics Identifies Distinct Molecular Classes of Neuroblastoma and Shows That Multiple Genes Are Targeted by Regional Alterations in DNA Copy Number
Defective Oxidative Phosphorylation in Thyroid Oncocytic Carcinoma Is Associated with Pathogenic Mitochondrial DNA Mutations Affecting Complexes I and III
Cell, Tumor, and Stem Cell Biology
Bmi-1 Is a Novel Molecular Marker of Nasopharyngeal Carcinoma Progression and Immortalizes Primary Human Nasopharyngeal Epithelial Cells
Experimental Therapeutics, Molecular Targets, and Chemical Biology
Bone Sialoprotein Mediates the Tumor Cell–Targeted Prometastatic Activity of Transforming Growth Factor β in a Mouse Model of Breast Cancer
Combined DNA Methyltransferase and Histone Deacetylase Inhibition in the Treatment of Myeloid Neoplasms
Immunology
Frequent Loss of HLA-A2 Expression in Metastasizing Ovarian Carcinomas Associated with Genomic Haplotype Loss and HLA-A2-Restricted HER-2/neu-Specific Immunity
Association of Antigen-Processing Machinery and HLA Antigen Phenotype of Melanoma Cells with Survival in American Joint Committee on Cancer Stage III and IV Melanoma Patients
Clinical Research
Epidemiology and Prevention
Hormone-Induced Protection against Mammary Tumorigenesis Is Conserved in Multiple Rat Strains and Identifies a Core Gene Expression Signature Induced by Pregnancy
Letter to the Editor
Correction
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.